- Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
- Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
- Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
- Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
- Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
- Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
- Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
- Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
- Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
As of last trade, Helius Medical Technologies Inc (HSDT:NAQ) traded at 1.39, 22.01% above the 52 week low of 1.14 set on May 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.46 |
---|---|
High | 1.46 |
Low | 1.39 |
Bid | 1.39 |
Offer | 1.42 |
Previous close | 1.41 |
Average volume | 183.63k |
---|---|
Shares outstanding | 2.53m |
Free float | 2.51m |
P/E (TTM) | -- |
Market cap | 3.57m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 03 2024 18:02 BST.
More ▼